Epidemiology of axial spondyloarthritis: an update
- PMID: 29227352
- PMCID: PMC5811203
- DOI: 10.1097/BOR.0000000000000475
Epidemiology of axial spondyloarthritis: an update
Abstract
Purpose of review: To provide an update of the prevalence and incidence of axial spondyloarthritis in the general population and in patients with spondyloarthritis-related conditions, environmental risk factors for ankylosing spondylitis, progression from nonradiographic axial spondyloarthritis to ankylosing spondylitis, mortality, and risks for cardiovascular events in patients with ankylosing spondylitis.
Recent findings: Increasingly, administrative healthcare data have been used to study disease frequency and outcomes. The prevalence of ankylosing spondylitis ranged from 9 to 30 per 10 000 persons, which are lower than previous estimates. Data on whether childhood infections influence the risk of ankylosing spondylitis were equivocal, while having been breast-fed may be protective. Progression of patients with nonradiographic axial spondyloarthritis to ankylosing spondylitis is slow, with estimates of 5.1% in 5 years and 19% in 10 years. Risk of mortality is slightly increased in ankylosing spondylitis. Risks for cardiovascular events in ankylosing spondylitis were either not different from, or only slightly higher than in controls. No studies have examined these outcomes in the broader group of patients with axial spondyloarthritis.
Summary: Expanded use of administrative and registry data has facilitated studies of the epidemiology of ankylosing spondylitis, but lack of specific diagnostic codes limits use of these resources for studying axial spondyloarthritis in general.
Conflict of interest statement
None.
Similar articles
-
Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis.Clin Rheumatol. 2021 Apr;40(4):1361-1367. doi: 10.1007/s10067-020-05415-7. Epub 2020 Sep 24. Clin Rheumatol. 2021. PMID: 32974836
-
Presence of Fibromyalgia Syndrome and Its Relationship with Clinical Parameters in Patients with Axial Spondyloarthritis.Pain Physician. 2019 Nov;22(6):E579-E585. Pain Physician. 2019. PMID: 31775411
-
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.Arthritis Care Res (Hoboken). 2019 Oct;71(10):1285-1299. doi: 10.1002/acr.24025. Epub 2019 Aug 21. Arthritis Care Res (Hoboken). 2019. PMID: 31436026 Free PMC article. Review.
-
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075-017-1315-z. Arthritis Res Ther. 2017. PMID: 28521824 Free PMC article.
-
Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment.Curr Opin Rheumatol. 2014 Jul;26(4):377-83. doi: 10.1097/BOR.0000000000000071. Curr Opin Rheumatol. 2014. PMID: 24807404 Review.
Cited by
-
Health state utility values in patients with Ankylosing Spondylitis: a systematic review and meta-analysis.Qual Life Res. 2024 Jun 1. doi: 10.1007/s11136-024-03670-8. Online ahead of print. Qual Life Res. 2024. PMID: 38824212 Review.
-
Single-cell transcriptome revealed dysregulated RNA-binding protein expression patterns and functions in human ankylosing spondylitis.Front Med (Lausanne). 2024 May 6;11:1369341. doi: 10.3389/fmed.2024.1369341. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38770048 Free PMC article.
-
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort.Sci Rep. 2024 May 6;14(1):10342. doi: 10.1038/s41598-024-61001-w. Sci Rep. 2024. PMID: 38710901 Free PMC article.
-
Causal relationship between the immune cells and ankylosing spondylitis: univariable, bidirectional, and multivariable Mendelian randomization.Front Immunol. 2024 Apr 9;15:1345416. doi: 10.3389/fimmu.2024.1345416. eCollection 2024. Front Immunol. 2024. PMID: 38655262 Free PMC article.
-
Inflammatory bowel disease activity threatens ankylosing spondylitis: implications from Mendelian randomization combined with transcriptome analysis.Front Immunol. 2024 Feb 28;15:1289049. doi: 10.3389/fimmu.2024.1289049. eCollection 2024. Front Immunol. 2024. PMID: 38482005 Free PMC article.
References
-
- Barnabe C, Jones CA, Bernatsky S, et al. Inflammatory Arthritis Prevalence and Health Services Use in the First Nations and Non–First Nations Populations of Alberta, Canada. Arthritis Care Res. 2017;69:467–74. - PubMed
-
- Dean LE, Macfarlane GJ, Jones GT. Differences in the prevalence of ankylosing spondylitis in primary and secondary care: only one-third of patients are managed in rheumatology. Rheumatology. 2016;55:1820–5. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials